您的位置: 首页 > 农业专利 > 详情页

PROGESTERONE RECEPTOR ANTAGONIST DOSAGE FORM
专利权人:
BAYER PHARMA AKTIENGESELLSCHAFT
发明人:
SCHUTT, BARBARA,SCHULTZE-MOSGAU, MARCUS-HILLERT,KAISER, ANDREAS
申请号:
PH12015502326
公开号:
PH12015502326A1
申请日:
2015.10.07
申请国别(地区):
PH
年份:
2016
代理人:
摘要:
The invention is directed to a pharmaceutical composition comprising a progesterone receptor antagonist namely (11 B,17B)-17-Hydroxy-11-[4-(methylsulphonyl)phenyl]-17-(pentafluoroethyl)estra-4,9-dien-3-one at the dosage of about 0.5 to 5 mg and more particularly 2 mg. Additionally, the invention is directed to the use of the novel pharmaceutical composition for treatment of and/or prophylaxis of gynaecological diseases, such as fibroids of the uterus (myomas, uterine leiomyoma), endometriosis or excessive menstrual bleeds, and method for obtaining such composition and oral dosage form.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充